We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Select Better Antibodies Using NGS Data

Credit: iStock

Antibody development holds the key to many effective drugs. However, the process of selecting the best candidates remains limited by the screening capabilities and investment costs of next-generation sequencing (NGS) techniques.

This whitepaper explores the cutting-edge cloud-based antibody selection tools, that provide confident and timely antibody selection. It also highlights the latest analysis software for independent, intricate analyses and optimal antibody selection.

Download this whitepaper to discover:

  • An accelerated discovery workflow that explores multiple characteristics from sequence, assay and in silico predicted data
  • How to de-risk antibody development by annotating structural liabilities
  • How to perform hit expansion, selection and enrichment analyses easily
Brought to you by
Access This Whitepaper for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.